{"id":"NCT00410410","sponsor":"Bristol-Myers Squibb","briefTitle":"A Study of Abatacept in Patients With Active Ulcerative Colitis","officialTitle":"A Phase 3, Multi-Center, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With Abatacept in Subjects With Active Ulcerative Colitis (UC) Who Have Had an Inadequate Clinical Response and/or Intolerance to Medical Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2009-06","completion":"2009-11","firstPosted":"2006-12-12","resultsPosted":"2010-12-02","lastUpdate":"2015-03-24"},"enrollment":591,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Ulcerative Colitis"],"interventions":[{"type":"DRUG","name":"abatacept (ABA)","otherNames":["Orencia","BMS-188667"]},{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"abatacept","otherNames":["Orencia","BMS-188667"]}],"arms":[{"label":"Abatacept (ABA)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"abatacept","type":"OTHER"}],"summary":"The purpose of this clinical research study is to learn if abatacept can improve signs and symptoms of active ulcerative colitis in patients who have not had an adequate response to other therapies. The safety of this treatment will also be studied","primaryOutcome":{"measure":"Induction Period (IP); Number of Participants With Clinical Response (Per Mayo Score) at Week 12: IP Cohort 1 (IP1C)","timeFrame":"Week 12 (Day IP-85)","effectByArm":[{"arm":"Induction Period Cohort 1 (IP1C)-ABA 30/~10 mg/kg","deltaMin":30,"sd":null},{"arm":"IP1C-ABA ~10 mg/kg","deltaMin":26,"sd":null},{"arm":"IP1C-ABA 3 mg/kg","deltaMin":14,"sd":null},{"arm":"IP1C-Placebo","deltaMin":41,"sd":null}],"pValues":[{"comp":"OG000 vs OG003","p":"0.124"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":null},"locations":{"siteCount":143,"countries":["United States","Australia","Belgium","Brazil","Canada","Czechia","France","Germany","India","Ireland","Italy","Mexico","Netherlands","Poland","Puerto Rico","South Africa","South Korea","Switzerland","United Kingdom"]},"refs":{"pmids":["22504093"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":22,"n":141},"commonTop":["HEADACHE","NAUSEA","NASOPHARYNGITIS","PYREXIA","FATIGUE"]}}